Clinical Trial Update: Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and immunogenicity of an RSV-F vaccine in elderly adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV F vaccine (RSV F protein vaccine)

Snippet

Sponsor: Novavax | Conditions: Respiratory Syncytial Virus (RSV) | Phase 2 | Status: COMPLETED